P-Terphenyl curtisian E inhibits in vitro platelet aggregation via cAMP elevation and VASP phosphorylation

Vascular Pharmacology

Volumn 59, Issue 3-4, 2013, Pages 83-89

  Kamruzzaman, Sordar Mohammed ^a   Yayeh, Taddesse ^b   Ji, Hyun Dong ^b   Park, Ji Young ^b   Kwon, Young Sam ^b   Lee, In Kyoung ^c   Kim, Suk ^d   Oh, Seung Hyun ^e   Kim, Sung Dae ^f   Roh, Seong Soo ^g   Yun, Bong Sik ^c   Rhee, Man Hee ^b  

^a UNIVERSITY OF RAJSHAHI   (Bangladesh)

^b Kyungpook National University   (South Korea)

^c Chonbuk National University   (South Korea)

^d Gyeongsang National University   (South Korea)

^e Gachon University   (South Korea)

^f Dongnam Institute of Radiological and Medical Science   (South Korea)

^g Daegu Haany University   (South Korea)

Author keywords

Curtisian E; Cyclic adenosine monophosphate; Mitogen activated protein kinases; Platelets; Vasodilator stimulated phosphoprotein

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANTITHROMBOCYTIC AGENT; COLLAGEN; CURTISIAN E; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; FIBRONECTIN; FORSKOLIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; THROMBIN; UNCLASSIFIED DRUG; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ANTICOAGULATION; ARTICLE; CALCIUM CELL LEVEL; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; UPREGULATION;

CURTISIAN E; CYCLIC ADENOSINE MONOPHOSPHATE; MITOGEN ACTIVATED PROTEIN KINASES; PLATELETS; VASODILATOR-STIMULATED-PHOSPHOPROTEIN;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; AGARICALES; ANIMALS; CALCIUM; CELL ADHESION MOLECULES; COLLAGEN; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBRINOLYTIC AGENTS; MALE; MICROFILAMENT PROTEINS; PHENYLACETATES; PHOSPHOPROTEINS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; TERPHENYL COMPOUNDS; THROMBIN;

EID: 84885311900     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2013.07.002     Document Type: Article

References (37)

1. Adam F., Kauskot A., Nurden P., Sulpice E., Hoylaerts M.F., Davis R.J., et al. Platelet JNK1 is involved in secretion and thrombus formation. Blood 2010, 115:4083-4092.
2. Ali N., Srey R., Pavlakis S. Hemoglobinopathies and stroke: strategies for prevention and treatment. Curr Treat Options Cardiovasc Med 2012, 14:227-236.
3. Blair P., Flaumenhaft R. Platelet alpha-granules: basic biology and clinical correlates. Blood Rev 2009, 23:177-189.
4. Cho J., Mosher D.F. Enhancement of thrombogenesis by plasma fibronectin cross-linked to fibrin and assembled in platelet thrombi. Blood 2006, 107:3555-3563.
5. Coles B., Bloodsworth A., Eiserich J.P., Coffey M.J., McLoughlin R.M., Giddings J.C., et al. Nitrolinoleate inhibits platelet activation by attenuating calcium mobilization and inducing phosphorylation of vasodilator-stimulated phosphoprotein through elevation of cAMP. J Biol Chem 2002, 277:5832-5840.
6. Doljak B., Cateni F., Anderluh M., Procida G., Zilic J., Zacchigna M. Glycerolipids as selective thrombin inhibitors from the fungus Stereum hirsutum. Drug Dev Ind Pharm 2006, 32:635-643.
7. Endale M., Lee W.M., Kamruzzaman S.M., Kim S.D., Park J.Y., Park M.H., et al. Ginsenoside-Rp1 inhibits platelet activation and thrombus formation via impaired glycoprotein VI signalling pathway, tyrosine phosphorylation and MAPK activation. Br J Pharmacol 2012, 167:109-127.
8. Flevaris P., Li Z., Zhang G., Zheng Y., Liu J., Du X. Two distinct roles of mitogen-activated protein kinases in platelets and a novel Rac1-MAPK-dependent integrin outside-in retractile signaling pathway. Blood 2009, 113:893-901.
9. Gupta G.P., Massague J. Platelets and metastasis revisited: a novel fatty link. J Clin Invest 2004, 114:1691-1693.
10. Han J., Lim C.J., Watanabe N., Soriani A., Ratnikov B., Calderwood D.A., et al. Reconstructing and deconstructing agonist-induced activation of integrin alphaIIbbeta3. Curr Biol 2006, 16:1796-1806.
11. Heemskerk J.W., Siljander P.R., Bevers E.M., Farndale R.W., Lindhout T. Receptors and signalling mechanisms in the procoagulant response of platelets. Platelets 2000, 11:301-306.
12. Ina K., Ando T. The use of lentinan for treating gastric cancer. Anticancer Agents Med Chem 2012, 13:681-688.
13. Jackson S.P., Yap C.L., Anderson K.E. Phosphoinositide 3-kinases and the regulation of platelet function. Biochem Soc Trans 2004, 32:387-392.
14. Jang B.S., Kim J.C., Bae J.S., Rhee M.H., Jang K.H., Song J.C., et al. Extracts of Phellinus gilvus and Phellinus baumii inhibit pulmonary inflammation induced by lipopolysaccharide in rats. Biotechnol Lett 2004, 26:31-33.
15. Jose N., Ajith T.A., Janardhanan K.K. Methanol extract of the oyster mushroom, Pleurotus florida, inhibits inflammation and platelet aggregation. Phytother Res 2004, 18:43-46.
16. Kamruzzaman S.M., Endale M., Oh W.J., Park S.C., Kim T.H., Lee I.K., et al. Antiplatelet activity of Phellinus baummii methanol extract is mediated by cyclic AMP elevation and inhibition of collagen-activated integrin-alpha(IIb) beta and MAP kinase. Phytother Res 2011, 25:1596-1603.
17. Kansra S.V., Shukla S.D. Reverse relationship between mitogen activated protein kinase and human platelet aggregation. Clin Exp Hypertens 2000, 22:145-154.
18. Laurance S., Lemarie C.A., Blostein M.D. Growth arrest-specific gene 6 (gas6) and vascular hemostasis. Adv Nutr 2012, 3:196-203.
19. Lee D.H., Cho H.J., Kang H.Y., Rhee M.H., Park H.J. Total saponin from Korean red ginseng inhibits thromboxane A2 production associated microsomal enzyme activity in platelets. J Ginseng Res 2012, 36:40-46.
20. Lee H.S., Kim S.D., Lee W.M., Endale M., Kamruzzaman S.M., Oh W.J., et al. A noble function of BAY 11-7082: inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations. Eur J Pharmacol 2010, 627:85-91.
21. Lee I.K., Han M.S., Lee M.S., Kim Y.S., Yun B.S. Styrylpyrones from the medicinal fungus Phellinus baumii and their antioxidant properties. Bioorg Med Chem Lett 2010, 20:5459-5461.
22. Lee I.K., Yun B.S., Kim J.P., Kim W.G., Ryoo I.J., Oh S., et al. p-Terphenyl curtisians protect cultured neuronal cells against glutamate neurotoxicity via iron chelation. Planta Med 2003, 69:513-517.
23. Leoncini G., Bruzzese D., Signorello M.G., Armani U., Piana A., Ghiglione D., et al. Platelet activation by collagen is increased in retinal vein occlusion. Thromb Haemost 2007, 97:218-227.
24. Li Z., Ajdic J., Eigenthaler M., Du X. A predominant role for cAMP-dependent protein kinase in the cGMP-induced phosphorylation of vasodilator-stimulated phosphoprotein and platelet inhibition in humans. Blood 2003, 101:4423-4429.
25. Pancioli A.M., Brott T.G. Therapeutic potential of platelet glycoprotein IIb/IIIa receptor antagonists in acute ischaemic stroke: scientific rationale and available evidence. CNS Drugs 2004, 18:981-988.
26. Seo S.R., Kim S.S., Chung K.C. Activation of adenylate cyclase by forskolin increases the protein stability of RCAN1 (DSCR1 or Adapt78). FEBS Lett 2009, 583:3140-3144.
27. Stojanovic A., Marjanovic J.A., Brovkovych V.M., Peng X., Hay N., Skidgel R.A., et al. A phosphoinositide 3-kinase-AKT-nitric oxide-cGMP signaling pathway in stimulating platelet secretion and aggregation. J Biol Chem 2006, 281:16333-16339.
28. Sudo T., Ito H., Kimura Y. Phosphorylation of the vasodilator-stimulated phosphoprotein (VASP) by the anti-platelet drug, cilostazol, in platelets. Platelets 2003, 14:381-390.
29. Toth-Zsamboki E., Oury C., Cornelissen H., De Vos R., Vermylen J., Hoylaerts M.F. P2X1-mediated ERK2 activation amplifies the collagen-induced platelet secretion by enhancing myosin light chain kinase activation. J Biol Chem 2003, 278:46661-46667.
30. Tran H., Anand S.S. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease. JAMA 2004, 292:1867-1874.
31. Wangorsch G., Butt E., Mark R., Hubertus K., Geiger J., Dandekar T., et al. Time-resolved in silico modeling of fine-tuned cAMP signaling in platelets: feedback loops, titrated phosphorylations and pharmacological modulation. BMC Syst Biol 2011, 5:178.
32. Wasser S.P. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol 2002, 60:258-274.
33. Wentworth J.K., Pula G., Poole A.W. Vasodilator-stimulated phosphoprotein (VASP) is phosphorylated on Ser157 by protein kinase C-dependent and -independent mechanisms in thrombin-stimulated human platelets. Biochem J 2006, 393:555-564.
34. Wijeyewickrema L.C., Berndt M.C., Andrews R.K. Snake venom probes of platelet adhesion receptors and their ligands. Toxicon 2005, 45:1051-1061.
35. Yayeh T., Oh W.J., Park S.C., Kim T.H., Cho J.Y., Park H.J., et al. Phellinus baumii ethyl acetate extract inhibits lipopolysaccharide-induced iNOS, COX-2, and proinflammatory cytokine expression in RAW264.7 cells. J Nat Med 2012, 66:49-54.
36. Yun B.S., Lee I.K., Kim J.P., Yoo I.D. Curtisians A-D, new free radical scavengers from the mushroom Paxillus curtisii. J Antibiot 2000, 53:114-122.
37. Zhang Y., Dai L., Kong X., Chen L. Characterization and in vitro antioxidant activities of polysaccharides from Pleurotus ostreatus. Int J Biol Macromol 2012, 51:259-265.